discovered Krebs von den Lungen‐6 (KL‐6), a high‐molecular‐weight (200 kDa) glycoprotein expressed by type II alveolar pneumocytes [6] in the alveolar space in response to cell damage and regeneration in patients with ILD [7]. This evidence concerns the gene MUC1 and interstitial lung disease.